Juan Moisés Ocampo-Godínez

Juan Moisés Ocampo-Godínez

Auto-generated profile, based on publicly available information

Juan Moisés Ocampo-Godínez


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2020 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
JRJosé Pablo Romero-López
José Pablo Romero-López
MCMartha Carnalla‐Cortés
Martha Carnalla‐Cortés
DPDiana L. Pacheco‐Olvera
Diana L. Pacheco‐Olvera
JOJuan Moisés Ocampo‐Godínez
Juan Moisés Ocampo‐Godínez
JRJacqueline Oliva Ramirez
Jacqueline Oliva Ramirez
LJLuis Jiménez‐Zamudio
Luis Jiménez‐Zamudio

23 August 2022 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
ARAlan Rios-Espinosa
Alan Rios-Espinosa
MCMagdalena Cruz-Luna
Magdalena Cruz-Luna
CGCarolina Garmendia-Gallardo
Carolina Garmendia-Gallardo
MHMerle Yasmin Hernández-Castañón
Merle Yasmin Hernández-Castañón
VHVerónica Yazmin Hernández-Hernández
Verónica Yazmin Hernández-Hernández
JOJuan Moises Ocampo-Godínez
Juan Moises Ocampo-Godínez

Verified
Journal Article
Open access
PDF file
JGJosé Luis González-Quiroz
José Luis González-Quiroz
JOJuan Moisés Ocampo-Godínez
Juan Moisés Ocampo-Godínez
VHVictoria Noemi Hernández-González
Victoria Noemi Hernández-González
RLRuth Angélica Lezama
Ruth Angélica Lezama
EMElba Reyes Maldonado
Elba Reyes Maldonado
MDMaria Lilia Dominguez-Lopez
Maria Lilia Dominguez-Lopez
Three-dimensional cell cultures have improved the evaluation of drugs for cancer therapy, due to their high similarity to solid tumors. In melanoma, autophagy appears to show a dual role depending on the progression of the disease. p62 protein has been proposed for the evaluation of autophagic flux since its expression is an indicator of the state of autophagy. Pentoxifylline (PTX) and Norcantharidin (NCTD) are drugs that have been shown to possess anticancer effects. In this work, we used B16F1 mouse melanoma cells in two-dimensional (2D) monolayer cultures and three-dimensional (3D) spheroids to test the effect of PTX and NCTD over the p62 expression. We analyzed the effect on p62 expression through Western blot and immunofluorescence assays. Our results indicate that PTX decreases p62 expression in both cell culture models, while Norcantharidin increases its expression in 3D cultures at 24 h. Therefore, these drugs could have a potential therapeutic use for the regulation of autophagy in melanoma, depending on the state of evolution of the disease.

15 April 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
JGJosé Luis González-Quiroz
José Luis González-Quiroz
JOJuan Moisés Ocampo-Godínez
Juan Moisés Ocampo-Godínez
VHVictoria Noemi Hernández-González
Victoria Noemi Hernández-González
RLRuth Angélica Lezama
Ruth Angélica Lezama
EMElba Reyes Maldonado
Elba Reyes Maldonado
MDMaria Lilia Dominguez-Lopez
Maria Lilia Dominguez-Lopez
3D cell cultures have improved the evaluation of drugs for cancer therapy, due to their high similarity to solid tumors. In melanoma, autophagy appears to show a dual role depending on the progression of the disease. p62 protein has been proposed for the evaluation of autophagic flux since its expression is an indicator of the state of autophagy. Pentoxifylline (PTX) and Norcantharidin (NCTD) are drugs that have been shown to have anticancer effects in various types of cancer. In this work, B16F1 mouse melanoma cell line was used, from which two-dimensional (2D) monolayer cultures and three-dimensional (3D) organoids were carried out using the hanging drop technique. The expression of p62 was determined by western blot and immunofluorescences. Our results indicate that pentoxifylline reduces p62 expression in both types of culture. While Norcantharidin increases its expression in 3D cultures at 24 h. Therefore, these drugs could have a potential therapeutic use for the regulation of autophagy in melanoma, depending on the state of evolution of the disease.

15 September 2025 in bioRxiv
Verified
Preprint
Open access
JOJessica C. Orr
Jessica C. Orr
EHElizabeth K. Haughey
Elizabeth K. Haughey
AFAndrew S. Farr
Andrew S. Farr
DPDavid R. Pearce
David R. Pearce
NMNiamh A. McCarthy
Niamh A. McCarthy
RHRobert E. Hynds
Robert E. Hynds
Modeling human epithelial diseases and developing cell-based therapies require robust methods to expand and manipulate epithelial stem and progenitor cells in vitro . Basal stem/progenitor cells from stratified epithelia can be expanded in 3T3-J2 fibroblast feeder cell co-culture systems, and the addition of the ROCK inhibitor Y-27632 enhances proliferation and culture longevity, a phenomenon described as ‘conditional reprogramming’. Here, we present a method incorporating the small molecule WS6 to further improve the proliferation and lifespan of cultured epithelial cells from multiple tissues, including airway, skin, and thymus. Cells maintained in this medium (‘EpMED’; FAD+Y+WS6) retain basal stem/progenitor cell identity and function, including the capacity to differentiate. We demonstrate their capacity to engraft in vivo in a tracheal transplantation model. In a second application, we generate clonal CRISPR-Cas9 genome edited nasal cultures, introducing targeted knockouts of DNAH5 or DNAI2 to create primary ciliary dyskinesia disease models. We anticipate that our method will have broad applications in epithelial cell biology, disease modeling, and regenerative medicine, while reducing reliance on immortalized or cancer cell lines and animal experimentation.

25 April 2024 in Research Square
Verified
Preprint
Open access
PDF file
JOJuan Ocampo-Godinez
Juan Ocampo-Godinez
PLPatricia Loranca-Moreno
Patricia Loranca-Moreno
CCCésar Cruz-Alcázar
César Cruz-Alcázar
MMMaricruz Dañino- Morales
Maricruz Dañino- Morales
SGStephany González-Cruz
Stephany González-Cruz
JNJael Vergara-Lope Nuñez
Jael Vergara-Lope Nuñez
Objective: This study compares the clinical improvement of genitourinary syndrome of menopause (GSM) and the capacity of vaginal biorevitalization between the gold standard treatment based on local hormonal therapy with estrogens (ES-based therapy) versus local therapy based on salmon polydeoxyribonucleotides (PDRNs-based therapy). Study design: Double blinded randomized clinical trial. The colposcopist and pathologist were blinded about which patient received one treatment or another. We randomly assigned 106 postmenopausal women (aged 38-77) with GSM. The control group (n=49) received ES-based therapy with bovine estrogen cream three times weekly. The treatment group (n=57) received vaginal suppositories from PDRNs only for six days every night during the first week. Main outcome measures: the severity of sexual and urinary problems, and the vaginal dryness using the Menopause Rating Scale (MRS). Moreover, alteration in vaginal pH and the atrophy of vaginal epithelium. Results: At 3 months of follow-up, the PDRNs-based therapy group presented a significantly decreased in the probability of presenting moderate-to-severe symptoms for sexual problems (OR= 0.07, CI 0.16-0.33, p<0.001), urinary problems (OR= 0.10, CI 002-0.50, p=0.004), vaginal dryness (OR= 0.17, CI 0.03-0.84, p=0.03), altered vaginal pH (pH>5) (OR= 0.20, CI 0.0.09-0.47, p<0.001) and atrophy of vaginal epithelium (OR= 0.02 CI 0.006-0.09, p<0.001) compared with the ES group. We also found a significant augmentation of intermediate cells in PDRNs-treated group (p=0.001). Conclusion: Our data suggest that PDRNs-based local therapy can biorevitalize the vagina and improve GSM in a clinically significant manner compared to the gold standard treatment with ES-based therapy (NCT05464654).